SEC Filing Details

Document Details

Filing Date
Jul 10, 2018
Document Date
Jul 10, 2018
Form Description
An amendment to the SC 13G filing
Filing Group
3,4,5
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline